Operating Lease, Right-of-Use Asset of Crinetics Pharmaceuticals, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Crinetics Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Crinetics Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $41,147,000, a 7% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Crinetics Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $41,147,000 -$3,119,000 -7% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $41,902,000 -$3,108,000 -6.9% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $42,694,000 -$3,066,000 -6.7% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $43,507,000 -$3,042,000 -6.5% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $44,266,000 -$3,776,000 -7.9% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $45,010,000 +$43,757,000 +3492% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $45,760,000 +$44,389,000 +3238% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $46,549,000 +$45,063,000 +3033% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $48,042,000 +$46,448,000 +2914% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $1,253,000 -$444,000 -26% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $1,371,000 -$426,000 -24% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $1,486,000 -$406,000 -21% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $1,594,000 -$389,000 -20% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $1,697,000 -$372,000 -18% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $1,797,000 -$355,000 -16% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $1,892,000 -$340,000 -15% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $1,983,000 -$323,000 -14% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $2,069,000 -$308,000 -13% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $2,152,000 -$293,000 -12% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $2,232,000 -$278,000 -11% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $2,306,000 -$264,000 -10% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $2,377,000 -$250,000 -9.5% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $2,445,000 -$238,000 -8.9% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $2,510,000 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 $2,570,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $2,627,000 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 $2,683,000 31 Mar 2019 10-Q 13 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.